Inventor
WEBER ECKARD
US73 patents
⚠️ This page may combine multiple inventors who share the name “WEBER ECKARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OREGON STATE
24 patentsUS5514680AMay 7, 1996
Glycine receptor antagonists and the use thereof
OREGON STATE206 citations99
US5093525AMar 3, 1992
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE124 citations98
US5262568ANov 16, 1993
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE91 citations97
US5336689AAug 9, 1994
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE90 citations96
US5312840AMay 17, 1994
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE51 citations96
US5308869AMay 3, 1994
Substituted amidines having high binding to the sigma receptor and the use thereof
OREGON STATE49 citations96
US5190976AMar 2, 1993
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE107 citations96
US5798390AAug 25, 1998
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE26 citations93
US5559154ASep 24, 1996
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE20 citations93
US5385946AJan 31, 1995
Method for treating hypertension with disubstituted granidine compounds
OREGON STATE66 citations93
US4906779AMar 6, 1990
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE115 citations93
US5620978AApr 15, 1997
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
OREGON STATE34 citations92
US5597922AJan 28, 1997
Glycine receptor antagonist pharmacophore
OREGON STATE22 citations92
US5011834AApr 30, 1991
PCP receptor ligands and the use thereof
OREGON STATE40 citations92
US4709094ANov 24, 1987
Sigma brain receptor ligands and their use
OREGON STATE82 citations91
US5502255AMar 26, 1996
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE21 citations89
US6251948B1Jun 26, 2001
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE17 citations84
US4975430ADec 4, 1990
CNQX and its analogs as therapeutics for degenerative neural diseases
OREGON STATE28 citations84
US5637622AJun 10, 1997
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE13 citations82
US5622952AApr 22, 1997
Glycine receptor antagonists and the use thereof
OREGON STATE14 citations82
US5478863ADec 26, 1995
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE16 citations82
US5631373AMay 20, 1997
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
OREGON STATE14 citations81
US5767162AJun 16, 1998
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE11 citations74
US5620979AApr 15, 1997
Glycine receptor antagonists and the use thereof
OREGON STATE7 citations74
CYTOVIA INC
7 patentsUS6342611B1Jan 29, 2002
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
CYTOVIA INC89 citations98
US6759207B2Jul 6, 2004
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
CYTOVIA INC46 citations96
US6355618B1Mar 12, 2002
Caspase inhibitors and the use thereof
CYTOVIA INC45 citations96
US6153591ANov 28, 2000
Dipeptide caspase inhibitors and the use thereof
CYTOVIA INC85 citations95
US6716818B2Apr 6, 2004
Caspase inhibitors and the use thereof
CYTOVIA INC22 citations92
US6566338B1May 20, 2003
Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
CYTOVIA INC31 citations92
US6495522B1Dec 17, 2002
Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
CYTOVIA INC31 citations91
NOVALAR PHARMACEUTICALS INC
7 patentsUS6872390B2Mar 29, 2005
Local anesthetic methods and kits
NOVALAR PHARMACEUTICALS INC35 citations94
US6764678B2Jul 20, 2004
Local anesthetic methods and kits
NOVALAR PHARMACEUTICALS INC59 citations94
US6432401B2Aug 13, 2002
Local anesthetic methods and kits
NOVALAR PHARMACEUTICALS INC41 citations94
US7261889B2Aug 28, 2007
Local anesthetic methods and kits
NOVALAR PHARMACEUTICALS INC21 citations91
US7575757B2Aug 18, 2009
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
NOVALAR PHARMACEUTICALS INC31 citations90
US7569230B2Aug 4, 2009
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
NOVALAR PHARMACEUTICALS INC32 citations90
US7229630B2Jun 12, 2007
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
NOVALAR PHARMACEUTICALS INC34 citations90
OREXIGEN THERAPEUTICS INC
3 patentsUS9125868B2Sep 8, 2015
Methods for administering weight loss medications
OREXIGEN THERAPEUTICS INC40 citations96
US7375111B2May 20, 2008
Compositions for affecting weight loss
OREXIGEN THERAPEUTICS INC60 citations96
US7462626B2Dec 9, 2008
Compositions for affecting weight loss
OREXIGEN THERAPEUTICS INC42 citations94
WARNER LAMBERT CO
3 patentsUS6124323ASep 26, 2000
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO54 citations96
US6130234AOct 10, 2000
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO17 citations92
US6448270B1Sep 10, 2002
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO6 citations74
MCKINNEY ANTHONY
3 patentsEURO CELTIQUE SA
1 patentNALPROPION PHARMACEUTICALS LLC
1 patentNALPROPION PHARMACEUTICALS INC
1 patentShowing the top 50 of 73 patents by PatentIndex Score.